Growing through innovation and Integration

Download Report

Transcript Growing through innovation and Integration

Strategic Outlook On Health Care From An Insurance Perspective
2008 Health Care Forecast Conference
February 22, 2008
Chip Tooke
Founder & former CEO Lumenos
Executive Chairman, Graphic Surgery
1
A Three Act Play
Act I:
Myth, Reality and The Money
Act II: The Triple Threat
Act III: What’s a Insurance Carrier to Do?
2
Act I
Myth, Reality and the Money
 The best health care on the planet, right?
 Most expensive health care delivery system in the world
 $2.1 trillion (16% GDP) ramping to $4 trillion (20% of GDP) in 6 years
3
Act I
Myth, Reality and the Money
 The best health care on the planet, right?
 Most expensive health care delivery system in the world
 $2.1 trillion (16% GDP) ramping to $4 trillion (20% of GDP) in 6 years
 Waste 20% to 30% of resource on care that does nothing to improve our
health ($500 to $700 billion)
 According to Rand, 55% of care meets adopted guidelines
 That means 45% does not – flip of the coin?
 Wide variation in health care services (Wennberg, Dartmouth Atlas)
 Poor performance on comparative health indicators
 Aging population; 50% of Americans have one or more chronic
diseases; personalized medicine on the horizon
4
A Simple Test
Answer “yes” or “no” to the following questions
1. I am within 5 pounds of my ideal body weight
2. I exercise 30 minutes or more on most days of the week
3. I eat a healthy diet – 5 fruits/vegetables most days of the week
4. I don’t use tobacco products
5. I consumer 2 or fewer alcoholic beverages a day
5
A Simple Test
Answer “yes” or “no” to the following questions
1. I am within 5 pounds of my ideal body weight
2. I exercise 30 minutes or more on most days of the week
3. I eat a healthy diet – 5 fruits/vegetables most days of the week
4. I don’t use tobacco products
5. I consumer 2 or fewer alcoholic beverages a day
YES: 4%
6
Behavior drives disease Costs of “the big three”
• Average 10% of total claims costs attributable to obesity
• 60% of Americans exceed ideal BMI
• Soon to become the leading cause of death
• Average 10% of total claims costs attributable to tobacco
• 25% of Americans smoke
• Leading cause of death. . . still
• 60% perform no substantial activity or exercise
62% of the rise in insurance costs from 1987-2002 due to population risk factors and their treatment
Source: Thorpe, et al, Health Affairs, June 2005
7
What if?
Mediterranean Diet, Nonsmoker, Daily
Activity & Moderate Alcohol Use
Disease
Reduction
Compared to US
Comment
Heart Disease
64%* - 83%**
80% due to modifiable
risk factors
Cancer
60%*
Approximates NCI
estimates
Diabetes
91% **
No Type II Epidemic
All-cause Mortality
50%*
25 year Okinawa
Program Similar
Findings
* Knoops et al and **Rimm, Stampfer, JAMA 2004;292:1433-1439
8
Behaviors Drive 50% of Costs
Assumes Average Total Compensation = $55,250
Source: U.S. Bureau of Labor Statistics,
Employer Costs For Employee Compensation Summary
Dec. 9, 2005.
9
Prevalence of Chronic Illnesses
More than 130 million Americans
suffer from chronic conditions;
that number will continue to rise.
145
Chronic
Condition
Diabetes
Prevalence
U.S. Population
20.8M
Heart Disease
60M
135
125
45
120
115
44
Asthma
30M
43
100
42
1995
2000
Chronic Conditions
2005
2010
% of Population
 $14B
 6.3M lost work
days
 14M lost school
days
110
105
 $277B
 5.9M lost work
days
47
% of Population
Population in Millions
140
46
 $132B
 11M lost work
days
48
130
Annual
Cost
Depression
21M
 $43B
 13.2M lost
work days
 $30B in lost
productivity
Source: NCQA State of Healthcare Quality Report, 2007
10
P4P: What Providers Fear (one of many)
Copyright Cartoon Bank
11
Act II: The Triple Threat
1. Little evidence that what we do works
 <15% of medicine based on evidence (David Eddy)
 4% of treatments backed up by firm science (IOM)
 50% have no or weak evidence (IOM)
2. The odds are barely in the patients’ favor (Rand)
 The odds of getting the right treatment ≈ the odds of getting the
wrong treatment
 Heads you win… tails you lose
3. Wide variations in care based on geography (Wennberg, Dartmouth
Atlas)
12
The Dartmouth Atlas
 Pick any elective surgical procedure
 Hemorrhoids in Vermont
 5 fold variation in a distance of less than 3 hours
 Back surgery
 3 times more likely in Idaho than Manhattan
 Tonsillectomy
 10 x variation from one region to another
 Hysterectomy
 5 fold variation
 In health care, the ordinary laws of nature don’t apply
 Roemer’s Law: Supply drives Demand
13
Act III
So, What’s a Smart Health Plan To Do?
14
Acknowledge:
We Live In A Rough Neighborhood
% of Adults
Supermarkets
39
Banks
34
Hospitals
34
Computer Hardware
27
Computer Software
22
Packaged Food
21
Airlines
“Which of these industries do you
think are generally honest and
trustworthy – so that you
normally believe a statement by a
company in that industry?”
17
Car Manufacturers
13
Telephone
11
Life Insurance
10
Pharmaceutical
9
Health Insurance
9
Managed Care
5
Tobacco
4
Oil
3
0
5
10
15
20
25
30
35
40
45
Source: Harris Poll, National Survey of 1,833 Adults, 10/05
15
The Consumer Experience
16
If you are over age 45, you may remember
(and yearn for) this experience
17
Winners’ Strategic To-Do List
 Accept where we are
 The lucrative arbitrage called insurance is over
 We are “middle men” and add little value from the consumers pov
 Stop digging
 Recognize the power base is shifting to the consumer
 Vast majority of employers want to exit, immediately if not sooner
 Start acting like problem solvers, not cost cutters
 Preoccupation with unit cost and utilization game is over
 Focus on what matters… to consumers
 Give people a reason to believe
 Recognize the power of “brand”
18
Winners’ Strategic To-Do List
 Provide real-time access to financial and medical data
 Google + Cleveland Clinic
 Launch aggressive programs focused on
 lowering risk factors (remember, this is where the illness/money lives)
 Increasing compliance with evidence-based medicine
 Give consumers an economic stake in the outcome
19
Winners’ Strategic To-Do List
 Give people the clinical data translated into behavioral action
 Most people make the right decision most of the time
 Informed consent is powerful: 24% reduction in surgery
 Spine surgery – new SPORT findings yesterday
 Get the data out there immediately
 Drugs are particularly vexing




Vioxx vs. naproxen, Lipitor vs. lovastatin
Why did prices on the top 50 drugs go up 7% last year?
How can I lower my cost?
Provide “point-of-prescription” data
 Help the sickest-of-the-sick navigate the chaos
 Reality: there is no “health care system”
20
What if the WellPoint Safety
Sentinel System was in place in 2000?
Vioxx Case Study
Signal Count
Serious
Adverse
Events
Analysis of our membership would have detected a signal
of increased cardiovascular events within 3-6 months
after FDA approval
Heart
Attacks
&
Strokes
Threshold
for Action
Timeline
Vioxx® History
Jan1998
May 1999
Hints of cardiovascular
issues in clinical trials
FDA
Approved
April 2001
Sept 2004
Vioxx
removed from Market
21
Why is this so hard?
 Health care: largest industry in our economy
 The business is mushy (sophisticated business term)
 Huge dollars at stake
 Eliminate $700 billion waste = eliminate the entire US high tech industry
 US expenditures on health care approaching world wide market for oil
 We spend more per capita on health care than China spends per capita…
on everything
22
Why is this so hard?
 Health care executives
 “I know, it’s a mess, but we are all doing quite well, thank you”
 “Trend is our friend”
 “I know our service sucks, but its slightly less sucky than the competition”
 “Innovators Dilemma” by Clayton Christensen
 The fundamental reason dominant companies don’t innovate?
 They don’t want to – it’s that simple (but read the book!)
 Creates a breeding ground for innovators… and a cemetery for BDCs
 “Overtreated - Why Too Much Medicine Is Making Us Sicker and Poorer”
by Shannon Brownlee
 NYT No. 1 Economics Book of 2007
23